- Home
- ATER vs PRTG Comparison
ATER vs PRTG Comparison
Compare ATER & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- PRTG
- Stock Information
- Founded
- ATER 2014
- PRTG 1973
- Country
- ATER United States
- PRTG British Virgin Islands
- Employees
- ATER N/A
- PRTG N/A
- Industry
- ATER Home Furnishings
- PRTG Oil & Gas Production
- Sector
- ATER Consumer Discretionary
- PRTG Energy
- Exchange
- ATER Nasdaq
- PRTG Nasdaq
- Market Cap
- ATER 15.5M
- PRTG 17.7M
- IPO Year
- ATER N/A
- PRTG N/A
- Fundamental
- Price
- ATER $1.36
- PRTG $5.61
- Analyst Decision
- ATER
- PRTG
- Analyst Count
- ATER 0
- PRTG 0
- Target Price
- ATER N/A
- PRTG N/A
- AVG Volume (30 Days)
- ATER 251.1K
- PRTG 231.6K
- Earning Date
- ATER 08-07-2025
- PRTG 08-26-2025
- Dividend Yield
- ATER N/A
- PRTG N/A
- EPS Growth
- ATER N/A
- PRTG N/A
- EPS
- ATER N/A
- PRTG N/A
- Revenue
- ATER $94,191,000.00
- PRTG N/A
- Revenue This Year
- ATER N/A
- PRTG N/A
- Revenue Next Year
- ATER $7.48
- PRTG N/A
- P/E Ratio
- ATER N/A
- PRTG N/A
- Revenue Growth
- ATER N/A
- PRTG N/A
- 52 Week Low
- ATER $1.22
- PRTG $2.10
- 52 Week High
- ATER $3.84
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- ATER 39.29
- PRTG 45.13
- Support Level
- ATER $1.46
- PRTG $5.25
- Resistance Level
- ATER $1.56
- PRTG $6.20
- Average True Range (ATR)
- ATER 0.11
- PRTG 0.49
- MACD
- ATER -0.01
- PRTG 0.13
- Stochastic Oscillator
- ATER 4.21
- PRTG 47.20
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.